肝硬化合并急性肾损伤的尿液相关预测因素分析

徐曼曼; 陈煜

doi:10.3969/j.issn.1001-5256.2018.10.013

肝硬化合并急性肾损伤的尿液相关预测因素分析

DOI: 10.3969/j.issn.1001-5256.2018.10.013

徐曼曼,
陈煜

首都医科大学附属北京佑安医院肝衰竭与人工肝治疗研究北京市重点实验室

基金项目:

国家科技重大专项“艾滋病和病毒性肝炎等重大传染病防治”专项基金资助项目(2012ZX10002004-006,2017ZX10203201-005,2017ZX10201201,2017ZX10202203-006-001,2017ZX10302201-004-002)；国家重点研发计划资助项目(2017YFA0103000)；吴阶平医学基金会肝病医学部肝硬化门脉高压并发症防治科研项目(LDWJPMF-102-17004)；北京市医院管理局“登峰”人才培养计划基金资助项目(DFL20151601)；

详细信息

中图分类号: R575.2;R692
计量
- 文章访问数: 2135
- HTML全文浏览量: 15
- PDF下载量: 387
- 被引次数: 0
出版历程
- 出版日期: 2018-10-20

An analysis of urinary factors for predicting acute kidney injury in patients with liver cirrhosis

Xu ManMan,
Chen Yu

Beijing Key Laboratory of Liver Failure and Artificial Liver Support Therapy, Beijing YouAn Hospital, Capital Medical University

Research funding:

摘要

摘要: 目的探讨肝硬化并发急性肾损伤（AKI）的预测因素。方法连续入组2017年5月-2018年4月于首都医科大学附属北京佑安医院就诊的肝硬化失代偿期患者105例,分为AKI组（49例）和非AKI组（56例）。收集患者临床一般资料以及实验室检查结果,留取患者入院时尿液标本,检测尿血管紧张素原（uAGT）、尿中性粒细胞明胶酶相关脂质运载蛋白（uNGAL）、尿肾损伤因子（KIM） 1,并以尿肌酐（UCr）校正。正态分布计量资料组间比较采用t检验,非正态分布计量资料组间比较采用Mann-Whitney U检验;计数资料组间比较采用χ2检验,进行logistic多因素分析,绘制受试者工作特征曲线（ROC曲线）评估预测效能。结果与非AKI组比较,AKI组患者合并上消化道出血及自发性腹膜炎的比例较高（χ2值分别为11. 420、8. 083,P值均<0. 05）,且白细胞计数、TBil、DBil、尿素氮、SCr均高于非AKI组（Z值分别为-3. 401、-2. 082、-2. 207、-5. 872、-7. 460,P值均<0. 05）,血Na低于非AKI组（t=-4. 905,P <0...
- 肝硬化 /
- 肾功能不全,急性 /
- 危险因素
Abstract: Objective To investigate the predictive factors for acute kidney injury ( AKI) in patients with liver cirrhosis. Methods A total of 105 patients with decompensated liver cirrhosis who visited Beijing YouAn Hospital from May 2017 to April 2018 were enrolled. These patients were divided into AKI group ( n = 49) and non-AKI group ( n = 56) . Their general information and laboratory results were collected, and urine samples were collected on admission to measure urinary angiotensinogen ( AGT) , urinary neutrophil gelatinase-associated lipocalin ( NGAL) , and urinary kidney injury molecule-1 ( KIM-1) , which were corrected for urinary creatinine ( UCr) . The t test was used for comparison of normally distributed continuous data between groups, and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data; the chi-square test was used for comparison of categorical data between groups. A multivariate logistic regression analysis was performed. The receiver operating characteristic ( ROC) curve was plotted to evaluate predictive efficiency. Results Compared with the non-AKI group, the AKI group had significantly higher proportions of patients with upper gastrointestinal bleeding and spontaneous bacterial peritonitis ( χ2= 11. 420 and 8. 083, both P < 0. 05) , significantly higher levels of leukocyte count, total bilirubin, direct bilirubin, urea nitrogen, and serum creatinine ( SCr) ( Z =-3. 401, -2. 082, -2. 207, -5. 872, and-7. 460, all P < 0. 05) , and a significantly lower level of blood sodium ( t =-4. 905, P < 0. 05) . The AKI group had significantly higher urinary NGAL/UCr and urinary KIM-1/UCr than the non-AKI group ( Z =-7. 654 and-2. 395, both P < 0. 05) . The multivariate analysis showed that SCr, blood sodium, and urinary NGAL/UCr were independent predictive factors for AKI in patients with liver cirrhosis ( all P < 0. 05) . The ROC curve analysis showed that at the cut-off value of 88. 1 μmol/L, SCr had a sensitivity of 93%, a specificity of 82%, and an area under the ROC curve ( AUC) of 0. 915 ( 95% confidence interval [CI]: 0. 850-0. 980) in predicting AKI; at the cut-off value of 1. 62 μg/g, urinary NGAL had a sensitivity of 87%, a specificity of 81%, and an AUC of 0. 950 ( 95% CI: 0. 911-0. 989) in predicting AKI; urinary NGAL combined with SCr had an AUC of 0. 964 ( 95% CI: 0. 931-0. 998) . Conclusion Urinary NGAL is an independent risk factor for AKI in patients with liver cirrhosis and can be used for the early diagnosis of AKI in these patients. Urinary AGT and KIM-1 cannot independently predict the development of AKI in liver cirrhosis, and their application value awaits further exploration.
- liver cirrhosis /
- renal insufficiency, acute /
- risk factors

HTML全文

参考文献(24)

[1]BELCHER JM, GARCIA-TSAO G, SANYAL AJ, et al.Association of AKI with mortality and complications in hospitalized patients with cirrhosis[J].Hepatology, 2013, 57 (2) :753-762.

[2]WONG F, O'LEARY JG, REDDY KR, et al.New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection[J].Gastroenterology, 2013, 145 (6) :1280-1288.

[3]BELCHER JM.Acute kidney injury in liver disease:Role of biomarkers[J].Adv Chronic Kidney Dis, 2015, 22 (5) :368-375.

[4]ARROYO V, FERNANDEZ J.Management of hepatorenal syndrome in patients with cirrhosis[J].Nat Rev Nephrol, 2011, 7 (9) :517-526.

[5]BELCHER JM, SANYAL AJ, PEIXOTO AJ, et al.Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury[J].Hepatology, 2014, 60 (2) :622-632.

[6]GUO DH, XU YQ.Clinical significance of urinary angiotensinogen[J].Chin J Integ Trad Western Nephrol, 2016, 17 (2) :187-188. (in Chinese) 郭冬华, 徐延琴.尿血管紧张素原的临床意义[J].中国中西医结合肾病杂志, 2016, 17 (2) :187-188.

[7]ZHANG XY, LYU WL, TENG J, et al.Correlation between urinary angiotensinogen and intrarenal renin-angiotensin system activity in chronic kidney disease patients[J].Chin J Nephrol, 2011, 27 (5) :327-332. (in Chinese) 章晓燕, 吕文律, 滕杰, 等.慢性肾脏病患者尿血管紧张素原与肾脏肾素血管紧张素系统活性的相关性[J].中华肾脏病杂志, 2011, 27 (5) :327-332.

[8]KOBORI H, OZAWA Y, SUZAKI Y, et al.Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats[J].J Am Soc Nephrol, 2005, 16 (7) :2073-2080.

[9]JURETZKO A, STEINBACH A, HANNEMANN A, et al.Urinary angiotensinogen and renin excretion are associated with chronic kidney disease[J].Kidney Blood Press Res, 2017, 42 (1) :145-155.

[10]BA AS, SANCHEZ A, BATLLE D.Angiotensinogen as a biomarker of acute kidney injury[J].Clin Kidney J, 2017, 10 (6) :759-768.

[11]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention andtreatment for chronic hepatitis B:a 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.

[12]ANGELI P, GINES P, WONG F, et al.Diagnosis and management of acute kidney injury in patients with cirrhosis:revised consensus recommendations of the International Club of Ascites[J].J Hepatol, 2015, 62 (4) :968-974.

[13]WAGENER G, JAN M, KIM M, et al.Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery[J].Anesthesiology, 2006, 105 (3) :485-491.

[14]ALGE JL, KARAKALA N, NEELY BA, et al.Urinary angiotensinogen predicts adverse outcomes among acute kidney injury patients in the intensive care unit[J].Crit Care, 2013, 17 (2) :r69.

[15]YANG X, CHEN C, TIAN J, et al.Urinary angiotensinogen level predicts AKI in acute decompensated heart failure:A prospective, two-stage study[J].J Am Soc Nephrol, 2015, 26 (8) :2032-2041.

[16]LI YM, ZHOU FF, LUO Q.Research progress of non-vasomotor mechanism for cirrhosis complicated by kidney injury[J].Chin JGen Prac, 2017, 15 (8) :1407-1410. (in Chinese) 李宇玫, 周芳芳, 罗群.肝硬化并发急性肾损伤的非血管舒张机制的研究进展[J].中华全科医学, 2017, 15 (8) :1407-1410.

[17]TSIGOU E, PSALLIDA V, DEMPONERAS C, et al.Role of new biomarkers:Functional and structural damage[J].Crit Care Res Pract, 2013, 2013:361078.

[18]KASHANI K, CHEUNGPASITPORN W, RONCO C.Biomarkers of acute kidney injury:The pathway from discovery to clinical adoption[J].Clin Chem Lab Med, 2017, 55 (8) :1074-1089.

[19]BARRETO R, FAGUNDES C, MOREIRA R, et al.Urinary kidney injury molecule-1 (Kim-1) in the assessment of acute kidney injury in patients with cirrhosis[J].J Hepatol, 2013, 58 (3) :419.

[20]ROGNANT N, LEMOINE S.Evaluation of renal function in patients with cirrhosis:Where are we now?[J].World J Gastroenterol, 2014, 20 (10) :2533-2541.

[21] BELCHER JM, SANYAL AJ, PEIXOTO AJ, et al.Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury[J].Hepatology, 2014, 60 (2) :622-632.

[22]GUNGOR G, ATASEVEN H, DEMIR A, et al.Neutrophil gelatinase-associated lipocalin in prediction of mortality in patients with hepatorenal syndrome:a prospective observational study[J].Liver Int, 2014, 34 (1) :49-57.

[23]FAGUNDES C, PEPIN MN, GUEVARA M, et al.Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis[J].J Hepatol, 2012, 57 (2) :267-273.

[24]XU CH, JIANG KR.Value of serum and urinary neutrophil gelatinase-associated lipocalin and cystatin C in diagnosis of liver cirrhosis complicated by acute kidney injury[H].J Clin Hepatol, 2017, 33 (11) :2136-2140. (in Chinese) 许长红, 江坤仁.血、尿中性粒细胞明胶酶相关脂质运载蛋白与胱抑素C对肝硬化并发急性肾损伤的诊断价值[J].临床肝胆病杂志, 2017, 33 (11) :2136-2140.

施引文献

资源附件(0)

访问统计